Accueil > Actualité
Actualite financiere : Actualite bourse

Regeneron: halts Covid-19 trial

(CercleFinance.com) - Sanofi and Regeneron Pharmaceuticals announce the halt of the Kevzara (sarilumab) phase III trial in patients with Covid-19 infection requiring mechanical ventilation, reporting adverse events.


Both the pharma groups also explain that this test did not meet its primary and secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo).

However, they state that a separate trial, piloted by Sanofi, using a different dosing regimen, is ongoing outside the US in hospitalised patients for a severe and critical form of Covid-19.


Copyright (c) 2020 CercleFinance.com. All rights reserved.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.